Virax Biolabs Group Ltd
Business
Virax Biolabs Group Ltd is a holding company that conducts operations through subsidiaries developing and commercializing in‑vitro diagnostics focused on T cell immunology and viral disease management. It offers T cell diagnostic assays and an immunology profiling platform under the ViraxImmune brand, and distributes third‑party IVD test kits via ViraxClear and ViraxVet. Its key business segments include ViraxImmune (R&D and IVD development) and distribution brands (ViraxClear/ViraxVet). The company markets products primarily in the United Kingdom, North America and the European Union through healthcare providers, laboratories, pharmacies and distributor channels.
Summary from filing dated 2025-07-02
Financials
Latest annual snapshot (FY2025, period end 2025-03-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-6.07M |
| Total assets | $6.43M |
| Total liabilities | $964.8K |
| Stockholders' equity | — |
| Operating cash flow | — |